- Filed
- Apr 23, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 30, 2025 | 268.4M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $7.26B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $7.26B |
| Short Term Debt | Q1 2025 · Mar 30, 2025 | $2.35B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.5B |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $1.24B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.7B |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $18.76B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $17.82B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $25.12B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $24.39B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $55.88B |
| Total Assets restated | Q1 2025 · Mar 31, 2024 | $55.88B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 277M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $105M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $361M |
| Capex | Q1 2025 · Mar 31, 2024 | $159M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$278M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $21.41B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $21.3B |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $627M |
| Net Income | Q1 2025 · Mar 31, 2024 | $799M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.04B |
| Revenue | Q1 2025 · Mar 31, 2024 | $10.73B |